Connect with us

Technology

Invest Smart, Grow Fast! Industries with Up to 20% Annual Growth

Published

on

“Discover High-Growth Opportunities Across Leading Sectors, With BCC Research Highlighting Industries Primed for Up to 20% Annual Returns”

BOSTON, Oct. 30, 2024 /PRNewswire/ — CAGR offers a clear view of long-term investment trends by balancing fluctuations for a steady growth rate. BCC Research reveals exciting growth opportunities, with specific industries poised for notable expansion—ideal for investors and stakeholders looking ahead.

1.  Zero Net Energy Buildings: Global Markets The global market for Zero Net Energy Buildings (ZNEBs) – which produce as much energy as they consume – is experiencing rapid growth. In 2022, the market size was $42.8 billion, but it’s expected to more than double to $109.2 billion by 2027. This represents an impressive annual growth rate of 20.6% over the next five years. As concern for climate change and energy efficiency continues to rise, the demand for ZNEBs is surging, driving innovation and investment in this sustainable and forward-thinking industry.

Microsoft: Microsoft’s Silicon Valley campus features a ZNEB design, with a focus on energy efficiency, renewable energy, and sustainable materials. The campus includes features like solar panels, green roofs, and advanced energy management systems to minimize energy consumption.Walgreens: Walgreens’ net-zero energy store in Evanston, Illinois, is a prime example of ZNEB in retail. The store features solar panels, wind turbines, and geothermal energy systems to power its operations. The building is designed to produce as much energy as it consumes over the course of a year.

2.  RNAi Drug Delivery: Technologies and Global Markets  The market for delivering RNA interference (RNAi) drugs, which use genetic material to treat diseases, is growing rapidly. Currently valued at $1.1 billion, it’s expected to nearly triple to $2.7 billion by 2028, with a remarkable annual growth rate of 20.5%. This surge is driven by advancements in technologies that help get these drugs into the body effectively, opening new possibilities for treating a range of medical conditions. As research and development continue to improve, the potential for RNAi drugs to revolutionize healthcare is vast, making this an exciting and promising field.

Alnylam Pharmaceuticals: Alnylam is a leading developer of RNAi therapeutics, with several approved treatments for rare genetic diseases. Their technology uses lipid nanoparticles to deliver RNAi drugs to specific cells, silencing disease-causing genes.Arrowhead Pharmaceuticals: Arrowhead is another prominent player in RNAi drug delivery, with a focus on developing treatments for liver and cardiovascular diseases. Their proprietary Targeted RNAi Molecule (TRiM) technology enables precise delivery of RNAi drugs to specific cells, reducing off-target effects.

3.  Biologics Development and Manufacturing Testing: Technologies and Global Markets The market for testing the safety of biologics, which are complex medicines made from living cells, is growing rapidly. Currently valued at $7.4 billion, it’s expected to more than double to $18.2 billion by 2027, with an impressive annual growth rate of 19.9%. This surge is driven by the increasing demand for biologics to treat various diseases, and the need for rigorous testing to ensure their safety and effectiveness. As biologics become more prevalent in healthcare, the importance of thorough testing and quality control grows, making this a critical and expanding field.

Pfizer: Pfizer, a global pharmaceutical giant, uses advanced biologics safety testing technologies to ensure the quality and efficacy of its biologic medicines. Their testing protocols include state-of-the-art analytical techniques, such as mass spectrometry and chromatography, to detect impurities and ensure product consistency.Biogen: Biogen, a leading biotechnology company, employs rigorous biologics safety testing methods to develop and manufacture innovative treatments for complex diseases. Their testing strategies include cutting-edge technologies like next-generation sequencing and advanced bioinformatics to identify potential safety risks and optimize product development.

4.  Viral Vector and Plasmid DNA: Technologies and Global Markets The market for viral vector and plasmid DNA technologies, which are crucial tools for developing gene therapies and vaccines, is experiencing rapid growth. Currently valued at $2.9 billion, it’s expected to more than double to $7.1 billion by 2028, with an impressive annual growth rate of 19.7%. This surge is driven by the increasing demand for innovative treatments for genetic diseases and infectious diseases, as well as advancements in technologies that enable precise gene editing and delivery. As researchers and companies continue to harness the power of genetic medicine, the demand for these technologies is skyrocketing, making this a dynamic and promising field.

Moderna Therapeutics: Moderna, a pioneering biotech company, uses viral vector technology to develop innovative mRNA-based vaccines and therapies. Their platform leverages a type of viral vector called lipid nanoparticles to deliver genetic material to cells, instructing them to produce specific proteins.Spark Therapeutics: Spark Therapeutics, a leading gene therapy company, utilizes viral vectors to develop treatments for inherited diseases. Their technology employs adeno-associated virus (AAV) vectors to deliver healthy copies of a gene to cells, replacing faulty or missing genes that cause disease.

5.  Inkjet Printing Technologies: Applications and Asia-Pacific Markets The market for inkjet printing technologies in the Asia-Pacific region is booming! Currently valued at $7.4 billion, it’s expected to more than double to $18.2 billion by 2028, growing at an impressive rate of 19.6% each year. This surge is driven by increasing demand for high-quality printing in various industries, such as textiles, ceramics, and packaging. Advancements in inkjet technology have made it faster, more precise, and cost-effective, making it an attractive option for businesses looking to enhance their printing capabilities. As a result, the Asia-Pacific market is poised for significant growth, with new opportunities emerging for companies that adopt this innovative technology.

Epson: Epson, a renowned electronics company, utilizes inkjet printing technology in its wide-format printers for various applications, including signage, textiles, and ceramics. Their proprietary Micro Piezo printheads enable precise droplet control, resulting in high-quality prints.Canon: Canon, a leading imaging and optical products company, employs inkjet printing technology in its production printers for high-speed, high-quality printing. Their inkjet technology is used in various industries, including commercial printing, packaging, and labels, offering efficient and reliable printing solutions.

6.  Global Electrical Vehicle Battery Market The market for electric vehicle (EV) batteries is rapidly accelerating! Was valued at $66.4 billion, it’s expected to nearly triple to $161.3 billion by 2028, growing at an impressive rate of 19.4% each year. This surge is driven by the increasing adoption of electric vehicles, government initiatives promoting sustainable transportation, and advancements in battery technology. As EVs become more mainstream, the demand for high-performance, efficient, and cost-effective batteries is skyrocketing, making this market a hotbed of innovation and growth. With major players investing heavily in research and development, the future of EV batteries looks bright and electrifying!

Tesla: Tesla, a pioneering electric vehicle manufacturer, designs and produces its own EV batteries, including the popular Lithium-Ion battery cells. Their battery technology powers their entire range of electric vehicles, including the Model S, Model 3, and Model Y.LG Chem: LG Chem, a leading chemical and battery manufacturer, supplies EV batteries to several major automotive companies, including General Motors, Ford, and Hyundai. Their advanced battery technology, including Lithium-Ion and Nickel-Manganese-Cobalt (NMC) batteries, enables efficient and reliable EV performance.

7.  Next-generation Sequencing: Emerging Clinical Applications and Global Markets The market for next-generation sequencing (NGS) in clinical settings is experiencing rapid growth! Currently valued at $21.9 billion, it’s expected to more than double to $52.9 billion by 2028, with an impressive annual growth rate of 19.3%. This surge is driven by the increasing adoption of NGS in healthcare, enabling precise diagnosis, personalized treatment, and targeted therapies. NGS technology allows for rapid and cost-effective analysis of genetic data, revolutionizing fields like oncology, infectious diseases, and rare genetic disorders. As a result, the demand for NGS in clinical applications is skyrocketing, transforming the way we approach patient care and treatment.

Illumina: Illumina, a leading biotechnology company, develops and markets NGS systems, including the popular HiSeq and NovaSeq platforms. Their technology enables rapid and accurate genetic analysis, driving advancements in cancer research, rare disease diagnosis, and personalized medicine.Thermo Fisher Scientific: A global life sciences company, Thermo Fisher Scientific offers a range of NGS solutions, including the Ion Torrent and Applied Biosystems platforms. Their technology supports various clinical applications, such as noninvasive prenatal testing, cancer profiling, and infectious disease detection.

8.  Global 5G Chipset Market The market for 5G chipsets is growing rapidly! In 2022, it was valued at $26.1 billion, and it’s expected to increase to $30 billion by 2023 and then more than double to $72 billion by 2028, with an impressive annual growth rate of 19.1%. This surge is driven by the increasing demand for high-speed, low-latency connectivity in various industries, including smartphones, laptops, and emerging technologies like autonomous vehicles and smart cities. As 5G networks continue to expand globally, the need for advanced chipsets that enable fast and reliable data transfer is skyrocketing, making this market a hotbed of innovation and growth.

Qualcomm: Qualcomm, a leading semiconductor company, designs and manufactures 5G chipsets, including the popular Snapdragon series, which powers many smartphones and laptops. Their 5G chipsets enable fast data transfer, low latency, and improved connectivity.Mediatek: Mediatek, a Taiwanese semiconductor company, produces 5G chipsets for various applications, including smartphones, tablets, and smart home devices. Their 5G chipsets offer high-speed connectivity, power efficiency, and advanced features like AI processing.

Get ready for a revolution! The explosive growth in emerging technologies like viral vectors, inkjet printing, electric vehicle batteries, next-generation sequencing, and 5G chipsets is transforming industries and creating unprecedented opportunities. As these markets soar, businesses and investors can expect a thrilling ride of innovation, sustainability, and boundless potential. Buckle up and join the journey to a brighter, more connected, and more sustainable future!

For further information or to make a purchase, please get in touch with info@bccresearch.com.

About BCC Research

BCC Research provides objective, unbiased measurement, and assessment of market opportunities with detailed market research reports. Our experienced industry analysts’ goal is to help you make informed business decisions, free of noise and hype.

Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/invest-smart-grow-fast-industries-with-up-to-20-annual-growth-302292013.html

Continue Reading

Technology

Cboe Clear U.S. Receives SEC Approval to Expand Clearing Capabilities

Published

on

By

SEC registration enables Cboe Clear U.S. to clear binary securities options alongside futures, positioning it to support innovation across the market

CHICAGO, Oct. 23, 2026 /PRNewswire/ — Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity and index derivatives, today announced that Cboe Clear U.S., LLC (CCUS) has received temporary registration from the U.S. Securities and Exchange Commission (SEC) to operate as a Covered Clearing Agency.

The registration expands CCUS’s clearing capabilities beyond its existing authorities as a Commodity Futures Trading Commission (CFTC)-registered Derivatives Clearing Organization (DCO) to clear securities products in addition to futures and swaps products. Together with recent enhancements to its regulatory framework and product scope, the milestone positions CCUS to support innovation and emerging opportunities across a broad range of assets and markets.

CCUS will initially use its SEC registration to clear Cboe’s binary securities options tied to specified corporate key performance indicators (KPIs), which are planned to list on Cboe Options Exchange and be available on Robinhood in the fourth-quarter 2026. CCUS also recently received CFTC approval to clear margined futures broadly and continues to clear digital asset derivatives under its DCO designation.

“Clearing plays a critical role in bringing innovation to market,” said Dale Michaels, Head of Cboe Clear U.S. “These expanded capabilities position Cboe Clear U.S. to become an innovation lane to support new products and meet evolving customer needs, while maintaining the rigorous risk management standards that are fundamental to our business.”

These efforts complement Cboe’s longstanding partnership with The Options Clearing Corporation (OCC)® and Cboe’s continued commitment to supporting the established clearing infrastructure for traditional equity options.

The development builds on the growth of Cboe’s established European clearing business, where Cboe Clear Europe has become the leading pan-European equities central counterparty, while expanding into new services such as securities financing transaction clearing. Together, these advances demonstrate Cboe’s ability to extend its clearing capabilities across markets and asset classes.

To support its own future growth, CCUS has strengthened its infrastructure over the past year, including electing in June to become a Subpart C DCO. In doing so, CCUS is voluntarily adopting the enhanced standards the CFTC applies to systemically important DCOs for financial resources, risk management and operational resilience, aligning with those applied to leading global clearing organizations.

About Cboe Global Markets

Cboe Global Markets (Cboe: CBOE) is a leading global markets operator with a long history of innovation in equity and index derivatives. Since launching the world’s first listed options exchange in 1973, Cboe has pioneered landmark products, including the introduction of S&P 500® index options and the creation of the VIX® Index, the world’s leading gauge of market volatility, reshaping how investors manage risk and access opportunity. Today, Cboe operates derivatives, equities, and FX markets, providing trading, clearing, and investment solutions for customers worldwide. To learn more, visit www.cboe.com.

Cboe Media Contacts

 

Cboe Analyst Contact

 

Angela Tu

+1-646-856-8734

atu@cboe.com

Tim Cave

+44 (0) 7593-506-719

tcave@cboe.com

Kenneth Hill, CFA

+1-312-786-7559

khill@cboe.com

CBOE-C
CBOE-OE

Cboe®, Cboe Global Markets®, and VIX ® are registered trademarks or service marks of Cboe Exchange, Inc and S&P 500® is a registered trademark of Standard & Poor’s Financial Services LLC. All other trademarks and service marks are the property of their respective owners. 

Cautionary Statements Regarding Forward-Looking Information

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. You can identify these statements by forward-looking words such as “may,” “might,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” and the negative of these terms and other comparable terminology. All statements that reflect our expectations, assumptions or projections about the future other than statements of historical fact are forward-looking statements. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from those expressed or implied by the forward-looking statements.

We operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Some factors that could cause actual results to differ include: the loss of our right to exclusively list and trade certain index options and futures products; economic, political and market conditions; compliance with legal and regulatory obligations; price and new products and services competition and consolidation in our industry; decreases in trading or clearing volumes, market data fees or a shift in the mix of products traded on our exchanges; legislative or regulatory changes or changes in tax regimes; our ability to protect our systems and communication networks from security vulnerabilities and breaches; our ability to attract and retain skilled management and other personnel; increasing competition by foreign and domestic entities; our business and operational dependence on and exposure to risk from third parties; factors that impact the quality and integrity of our and other applicable indices; our ability to manage our global operations, growth, and strategic acquisitions, wind downs, divestitures, or alliances effectively; increases in the cost of the products and services we use; our ability to operate our business without violating the intellectual property rights of others and the costs associated with protecting our intellectual property rights; our ability to minimize the risks, including our credit, liquidity, market, investment, counterparty, and default risks, associated with operating our  clearinghouses; our ability to accommodate trading and clearing volume and transaction traffic, including significant increases, without failure or degradation of performance of our systems; misconduct by those who use our markets or our products or for whom we clear transactions; challenges to our use of open source software code; our ability to meet our compliance obligations, including managing our business interests and our regulatory responsibilities; the loss of key customers or a significant reduction in trading or clearing volumes by key customers; damage to our reputation; the ability of our compliance and risk management methods to effectively monitor and manage our risks; restrictions imposed by our debt obligations and our ability to make payments on or refinance our debt obligations; our ability to maintain an investment grade credit rating; impairment of our goodwill, long-lived assets, investments or intangible assets; the accuracy of our estimates and expectations; and litigation risks and other liabilities. More detailed information about factors that may affect our actual results to differ may be found in our filings with the SEC, including in our Annual Report on Form 10-K for the year ended December 31, 2025 and other filings made from time to time with the SEC.

We do not undertake, and we expressly disclaim, any duty to update any forward-looking statement whether as a result of new information, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cboe-clear-us-receives-sec-approval-to-expand-clearing-capabilities-302918297.html

SOURCE Cboe Global Markets, Inc.

Continue Reading

Technology

Hears Everything, Uploads Nothing: VoxNexus Launches Android’s First Low-Power On-Device Always-On Voice Artificial Intelligence (AI)

Published

on

By

VoxNexus’ new on-device ambient listening solution runs for 12 hours on 2.49% of a phone’s battery and never sends audio to the cloud

MADRID, Oct. 23, 2026 /PRNewswire/ — VoxNexus (www.VoxNexus.ai) released VoxEdge, an on-device voice stack that brings speech recognition, translation and speech synthesis to affordable Android devices, entirely offline. VoxEdge supports speech recognition in 36 languages, translation in 103 languages, and speech synthesis in 45 languages—all running with no connection, no data bundle, and no cloud token bills.

AI should work for everyone, not just for speakers of a handful of mainstream languages. Yet across much of Africa, voice AI has been held back by scarce training data and the lack of targeted fine-tuning. Everyday speech also includes code-switching and dialect variation, while cloud-based inference costs can make deployment at scale expensive. 

VoxNexus’s solutions run entirely on device, and every query is free once the model is installed on the device. Its speech recognition model has as few as 65 million parameters and achieves a lower word error rate than open-source models nearly ten times its size.

“Under-resource languages aren’t small languages. Hundreds of millions of people speak them. Until now, AI models just haven’t learned them yet,” said Charles Shi, CEO of VoxNexus.

VoxNexus also launched VoxSense, an on-device ambient listening solution that uses only 162 mAh for 12 hours of continuous listening, around 2.5% of a 6,500 mAh phone battery. By keeping all processing on device, VoxSense makes always-on listening practical without draining the battery and without sending any audio to the cloud. Developers and device makers can easily integrate it through a license and a simple SDK. Developers can request a free trial here: www.VoxNexus.ai.

VoxSense and VoxEdge were unveiled at the MediaTek Dimensity 9600 launch in Madrid on October 19.

Distributed by APO Group on behalf of VoxNexus AI. 

About VoxNexus:
VoxNexus builds AI that hears and speaks — for everyone, everywhere, all the time. Its audio intelligence runs entirely on-device, delivering low latency, built-in privacy, and zero token cost across any device with a chip. VoxNexus is headquartered in Singapore. Website: www.VoxNexus.ai. Contact: public@voxnexus.ai  

VoxNexus demonstrates live on-device speech recognition at the MediaTek Dimensity 9600 launch in Madrid on Oct. 19, 2026. Spanish and English conversations were transcribed in real time on the phone, with no cloud connection. (Photo: VoxNexus) 

Speaks Your Language, No Internet Needed: VoxNexus Brings On-Device Voice Artificial Intelligence (AI) in 100+ Languages to Affordable Android Devices

View original content:https://www.prnewswire.com/news-releases/hears-everything-uploads-nothing-voxnexus-launches-androids-first-low-power-on-device-always-on-voice-artificial-intelligence-ai-302918304.html

SOURCE VoxNexus AI

Continue Reading

Technology

team.blue extends €1.1 billion of its Term Loan B to 2032 in the largest software Euro term loan issuance in the last 12 months

Published

on

By

GHENT, Belgium, Oct. 23, 2026 /PRNewswire/ — team.blue, a leading pan-European provider of digital solutions for small and medium-sized businesses (SMBs) backed by Hg, CPP Investments and Sofina, today announces the successful pricing of an amendment and maturity extension for €1.1 billion of its existing €1.35 billion Term Loan B. The transaction priced on 22 October 2026, with the refinanced tranche extended from September 2029 to July 2032, reinforcing the Company’s prudent capital structure approach.

Strong demand from a broad group of institutional investors enabled team.blue to upsize the transaction twice in-market, taking the final deal size to €1.1 billion from a minimum initial launch size of €500 million, despite recent credit market volatility. Pro forma for the transaction, c.90% of team.blue’s term debt now matures in 2032.

The transaction comes at a time of significant momentum for team.blue, with continued double-digit revenue growth and strong cash generation supporting its deleveraging trajectory. Its products help Europe’s SMBs get online, get customers, get paid and stay compliant, and AI-enabled products are increasingly driving new customer growth. team.blue continues to innovate across its portfolio, from smarter tools within its brands to secure European cloud hosting built for customers’ growing AI workloads. Its category-leading SaaS brands are also integrating with leading AI assistants, bringing team.blue’s products to customers wherever they work.

Transaction highlights

The largest software Euro term loan issuance in the last 12 months€1.1 billion Term Loan B, borrowed by team.blue Finco S.à r.l., maturing July 2032Priced at E + 425bps with a 0% floor and an OID of 98.5Upsized twice from an initial €500 million, reflecting a heavily oversubscribed order bookCorporate and facility ratings of B3 (Moody’s) and B (S&P), both with stable outlooksBofA acted as Global Coordinator and Left Lead Physical Bookrunner, alongside Barclays. ABN AMRO, BNP Paribas, Citi, ING and J.P. Morgan acted as Bookrunners

Jonathan Thackray, Chief Financial Officer of team.blue, said:
“We set out to extend €500 million of our Term Loan B, and the depth of support from our institutional investor base allowed us to go much further. This reflects confidence in team.blue’s highly recurring, cash-generative model and our position as a leading digital partner for Europe’s SMBs. It gives us the flexibility to keep innovating and investing in the digital and AI-enabled tools our customers rely on.”

About team.blue
team.blue is the pan-European digital partner for small and medium businesses, serving more than 3.5 million customers in 24 countries. From web hosting, domains, email and cloud and AI infrastructure to e-commerce, engagement, payments and compliance tools, team.blue helps SMBs get online, get customers, get paid and stay compliant. Supported by more than 4,000 employees, team.blue’s vision is to make online business success simpler, with artificial intelligence at every step. 

View original content:https://www.prnewswire.co.uk/news-releases/teamblue-extends-1-1-billion-of-its-term-loan-b-to-2032-in-the-largest-software-euro-term-loan-issuance-in-the-last-12-months-302918306.html

Continue Reading

Trending